These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 19632946

  • 21. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N.
    Cancer Res; 1990 Jan 01; 50(1):48-53. PubMed ID: 2152773
    [Abstract] [Full Text] [Related]

  • 22. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
    Ozkan EE.
    Mol Cell Endocrinol; 2011 Sep 15; 344(1-2):1-24. PubMed ID: 21782884
    [Abstract] [Full Text] [Related]

  • 23. The insulin-like growth factor system and sarcomas.
    Rikhof B, de Jong S, Suurmeijer AJ, Meijer C, van der Graaf WT.
    J Pathol; 2009 Mar 15; 217(4):469-82. PubMed ID: 19148905
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov 15; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Expression of genes belonging to the IGF-system in glial tumors.
    Dmitrenko VV, Kavsan VM, Boyko OI, Rymar VI, Stepanenko AA, Balynska OV, Malisheva TA, Rozumenko VD, Zozulya YP.
    Tsitol Genet; 2011 Nov 15; 45(5):41-57. PubMed ID: 22168049
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA, Bermudez E, Stewart W, Everitt JI, Walker CL.
    Cancer Res; 1995 Aug 15; 55(16):3634-9. PubMed ID: 7627973
    [Abstract] [Full Text] [Related]

  • 31. Insulin-like growth factor (IGF) axis in cancerogenesis.
    Kasprzak A, Kwasniewski W, Adamek A, Gozdzicka-Jozefiak A.
    Mutat Res Rev Mutat Res; 2017 Aug 15; 772():78-104. PubMed ID: 28528692
    [Abstract] [Full Text] [Related]

  • 32. Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells.
    Youssef A, Han VK.
    Endocrinology; 2016 Mar 15; 157(3):1163-74. PubMed ID: 26760116
    [Abstract] [Full Text] [Related]

  • 33. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
    Bieghs L, Johnsen HE, Maes K, Menu E, Van Valckenborgh E, Overgaard MT, Nyegaard M, Conover CA, Vanderkerken K, De Bruyne E.
    Oncotarget; 2016 Jul 26; 7(30):48732-48752. PubMed ID: 27129151
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Role of the IGF axis in prostate cancer.
    Biernacka KM, Perks CM, Holly JM.
    Minerva Endocrinol; 2012 Jun 26; 37(2):173-85. PubMed ID: 22691890
    [Abstract] [Full Text] [Related]

  • 36. Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation.
    Min HY, Boo HJ, Lee HJ, Jang HJ, Yun HJ, Hwang SJ, Smith JK, Lee HJ, Lee HY.
    Oncotarget; 2016 Oct 25; 7(43):70936-70947. PubMed ID: 27708216
    [Abstract] [Full Text] [Related]

  • 37. The consequences of insulin-like growth factors/receptors dysfunction in lung cancer.
    Pavelic J, Krizanac S, Kapitanovic S, Pavelic L, Samarzija M, Pavicic F, Spaventi S, Jakopovic M, Herceg-Ivanovi Z, Pavelic K.
    Am J Respir Cell Mol Biol; 2005 Jan 25; 32(1):65-71. PubMed ID: 15514114
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Targeting IGF-1 signaling pathways in gynecologic malignancies.
    Bruchim I, Werner H.
    Expert Opin Ther Targets; 2013 Mar 25; 17(3):307-20. PubMed ID: 23294364
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.